Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.940
-0.010 (-0.51%)
Jun 6, 2025, 2:45 PM CST

Kangmei Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
894.14977.841,0571,5072,419552.34
Upgrade
Trading Asset Securities
0.080.080.080.120.52-
Upgrade
Cash & Short-Term Investments
894.22977.921,0571,5082,419552.34
Upgrade
Cash Growth
20.07%-7.45%-29.90%-37.68%337.98%8.93%
Upgrade
Accounts Receivable
2,5142,5422,2492,0461,4602,487
Upgrade
Other Receivables
659.92823.86874.44888.791,0529,559
Upgrade
Receivables
3,1743,3663,1232,9352,51212,046
Upgrade
Inventory
2,5122,5102,6442,7513,1955,709
Upgrade
Prepaid Expenses
---0-0.01
Upgrade
Other Current Assets
313.1545.65-14.11190.85158.8234.39
Upgrade
Total Current Assets
6,8946,9006,8107,3848,28518,541
Upgrade
Property, Plant & Equipment
3,4543,5003,8754,1804,6429,603
Upgrade
Long-Term Investments
1.111.111.151.3911
Upgrade
Goodwill
106.35106.35106.35106.35106.3536.91
Upgrade
Other Intangible Assets
404.86409.47491.02529.79579.731,309
Upgrade
Long-Term Deferred Tax Assets
71.0374.36101.4896.9760.69240.96
Upgrade
Long-Term Deferred Charges
51.0855.0566.4786.71110.22111.57
Upgrade
Other Long-Term Assets
2,7322,7522,8292,7832,2693,483
Upgrade
Total Assets
13,71413,79814,28015,16916,05433,326
Upgrade
Accounts Payable
2,5052,5462,2562,5632,0153,762
Upgrade
Accrued Expenses
49.21520.42716.971,3281,1342,066
Upgrade
Short-Term Debt
3315.8326.1425.6215.172,315
Upgrade
Current Portion of Leases
25.7328.3540.7139.1236.89-
Upgrade
Current Income Taxes Payable
414.9927.724.7426.2140.5112.15
Upgrade
Current Unearned Revenue
140.22118.82159.89158.12193.85455.19
Upgrade
Other Current Liabilities
2,6502,6372,8751,3011,41114,576
Upgrade
Total Current Liabilities
5,8185,8946,1005,4424,94723,286
Upgrade
Long-Term Debt
-----19,415
Upgrade
Long-Term Leases
87.9194.95188.16199.13153.22-
Upgrade
Long-Term Unearned Revenue
547.64555.78618.68653.98692.971,035
Upgrade
Long-Term Deferred Tax Liabilities
24.7126.8551.6855.53-0.05
Upgrade
Other Long-Term Liabilities
17.7917.79241.311,835293.02-
Upgrade
Total Liabilities
6,4966,5897,2008,1856,08643,736
Upgrade
Common Stock
13,86413,86413,86413,86413,8644,974
Upgrade
Additional Paid-In Capital
18,78318,78318,78318,78318,78311,576
Upgrade
Retained Earnings
-24,358-24,367-24,375-24,478-21,790-29,706
Upgrade
Treasury Stock
-1,107-1,107-1,225-1,222-932.82-343.6
Upgrade
Comprehensive Income & Other
1.191.181.181.433.1-3.74
Upgrade
Total Common Equity
7,1837,1747,0486,9489,927-13,504
Upgrade
Minority Interest
35.0134.5532.8935.4341.92126.47
Upgrade
Shareholders' Equity
7,2187,2097,0806,9849,968-10,410
Upgrade
Total Liabilities & Equity
13,71413,79814,28015,16916,05433,326
Upgrade
Total Debt
146.65139.13255.01263.87205.2921,730
Upgrade
Net Cash (Debt)
747.57838.8801.681,2442,214-21,178
Upgrade
Net Cash Growth
52.95%4.63%-35.54%-43.82%--
Upgrade
Net Cash Per Share
0.050.060.080.090.16-1.53
Upgrade
Filing Date Shares Outstanding
13,86413,86413,86413,86413,8644,974
Upgrade
Total Common Shares Outstanding
13,86413,86413,86413,86413,8644,974
Upgrade
Working Capital
1,0761,007709.671,9423,338-4,745
Upgrade
Book Value Per Share
0.520.520.510.500.72-2.71
Upgrade
Tangible Book Value
6,6726,6586,4506,3129,240-14,849
Upgrade
Tangible Book Value Per Share
0.480.480.470.460.67-2.99
Upgrade
Buildings
-5,1195,2295,4015,6658,359
Upgrade
Machinery
-1,1621,162826.651,2062,799
Upgrade
Construction In Progress
-175.32210.56215.5263.651,630
Upgrade
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.